Preveta
Preveta offers AI-powered Care Navigation software built on clinical pathways for oncology, urology, and GI specialties. Their platform integrates EHR data into disease-specific pathways to inform care navigation, guiding navigators to collect targeted data and patient-reported outcomes. Clinical analytics then surfaces richer data insights and identifies patients for prioritized action. Preveta's solution aims to streamline care coordination, operationalize clinical pathways, and eliminate gaps in care, ultimately improving patient outcomes. They emphasize a feedback loop where health data continuously becomes cleaner and more valuable. The company targets healthcare providers seeking to elevate care coordination and manage patient pathways effectively.
Preveta
Preveta offers AI-powered Care Navigation software built on clinical pathways for oncology, urology, and GI specialties. Their platform integrates EHR data into disease-specific pathways to inform care navigation, guiding navigators to collect targeted data and patient-reported outcomes. Clinical analytics then surfaces richer data insights and identifies patients for prioritized action. Preveta's solution aims to streamline care coordination, operationalize clinical pathways, and eliminate gaps in care, ultimately improving patient outcomes. They emphasize a feedback loop where health data continuously becomes cleaner and more valuable. The company targets healthcare providers seeking to elevate care coordination and manage patient pathways effectively.
TL;DR
Product: AI-powered care navigation software built on clinical pathways for oncology, urology, and GI
Founded / HQ: 2018; Los Angeles, CA
Team size: ~21 employees
Funding: Approximately $8.52M total (latest funding event Dec 20, 2022)
Company Overview
Problem Domain
Care coordination and clinical-pathways operationalization for specialty and oncology care
Founded
2018
Industry
Healthtech / Healthcare SaaS
Funding Track Record
1950000.00
Seed financing reported at approximately $1.95M (published March 26, 2021)
Latest funding event dated Dec 20, 2022 (details not specified in provided evidence)
Investor Signal
“Participated in Techstars LA; reported investors include MaC Venture Capital, TSVC, and other early investors”